Investigating a new way to inhibit a protein involved in brain damage from traumatic injuries and Alzheimer's disease
Development of Molecular Probe Inhibitors of Pathogenic, Cytosolic Cathespin B in Traumatic Brain Injury and Alzheimers Disease Neurodegeneration
This study is looking at how a protein called cathepsin B might cause brain damage and problems with behavior in people with traumatic brain injury and Alzheimer's disease, and the researchers want to find ways to block its harmful effects to help improve treatment options for those affected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10652388 on NIH RePORTER |
What this research studies
This research focuses on understanding how a protein called cathepsin B contributes to brain damage and behavioral issues in patients with traumatic brain injury (TBI) and Alzheimer's disease (AD). The researchers aim to develop specific inhibitors that can target the harmful effects of cathepsin B in the brain without disrupting its normal functions. By using advanced molecular probes, they hope to create new therapeutic options that could improve outcomes for individuals suffering from these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with traumatic brain injury or Alzheimer's disease who are experiencing cognitive and behavioral deficits.
Not a fit: Patients with other forms of dementia or neurological disorders unrelated to traumatic brain injury or Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve the quality of life for patients with traumatic brain injury and Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in targeting cathepsin B in animal models, indicating potential for success in developing similar therapeutic approaches.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Hook, Vivian Y. H — University of California, San Diego
- Study coordinator: Hook, Vivian Y. H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.